Global Settlement Reached in Abilify MDL, Cases Stayed

PENSACOLA, Fla. — The makers of antipsychotic drug Abilify have entered into a global settlement of all cases pending on the federal multidistrict litigation docket in Florida federal court, according to a case management order.

The Feb. 26 order, issued by Judge M. Casey Rodgers of the U.S. District Court for the Northern District of Florida, says the global settlement was formally announced during a Feb. 20 case management conference. Since that time, the District Court has appointed claims administrators and set settlement deadlines.

The Judicial Panel on Multidistrict Litigation created the federal MDL docket in October 2016.